Nicolas Ferreyros, Managing Director, Community Oncology Alliance

COA Viewpoint

09/19/2023

Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.

Nicolas Ferreyros discusses the...

09/19/2023

Journal of Clinical Pathways

COA Viewpoint

A Commonsense Solution to Medicare Reimbursement

06/05/2023

Nicolas Ferreyros ;

Nicolas Ferreyos from the Community Oncology Alliance discusses the Strengthening Medicare for Patients and Providers Act (HR 2474) and what it means for both physicians and patients on Medicare.

Nicolas Ferreyos from the...

06/05/2023

Journal of Clinical Pathways

COA Viewpoint

Reforming the 340B Program to Put Drug Discounts in Patient Hands

11/16/2021

Nicolas Ferreyros ;

Nicolas Ferreyros discusses the 340B Drug Discount Program and explains changes that need to be made in order to help vulnerable patients with cancer.

Nicolas Ferreyros discusses the...

11/16/2021

Journal of Clinical Pathways

COA Viewpoint

Preliminary Comment Letter on Most Favored Nation Experiment and Impact on Older Adults With Cancer

12/16/2020

Nicolas Ferreyros ;

Warning of the dangerous impact it will have on seniors with cancer, the Community Oncology Alliance (COA) Board of Directors has submitted a preliminary comment letter to the Centers for Medicare & Medicaid...

...

12/16/2020

Journal of Clinical Pathways

Editorial

Attend #COA2020 to Prepare for What’s Next in Community Oncology

04/21/2020

Nicolas Ferreyros ;

Oncology is changing rapidly as models of care and reimbursement evolve. We have seen this firsthand with the rapid expansion of telehealth services to combat the COVID-19 (coronavirus) pandemic. This challenge to...

...

04/21/2020

Journal of Clinical Pathways

Editorial

Potential or Unnecessary Burdens and Challenges for Practices Under Proposed CMS Radiation Oncology Model

10/18/2019

Nicolas Ferreyros ;

In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...

In...

10/18/2019

Journal of Clinical Pathways

Editorial

The Real-Life Patient Impact of Pharmacy Benefit Managers

06/18/2019

Nicolas Ferreyros ;

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule for Medicare Part D that codified its decision to allow Medicare Advantage plans to use step therapy, or “fail first,” for new...

The...

06/18/2019

Journal of Clinical Pathways

Editorial

Busting the Myth of “Perverse Physician Incentives” to Prescribe High-Cost Drugs

04/16/2019

Nicolas Ferreyros ;

As proposals directed at reducing the cost of prescription drugs are being discussed at the national level, the Community Oncology Alliance (COA) has taken a closer look at the assertion that oncologists who...

As...

04/16/2019

Journal of Clinical Pathways

Editorial

#COA2019: The Most Comprehensive Meeting for Community Oncology

02/19/2019

Nicolas Ferreyros ;

The 2019 Community Oncology Conference will focus on ensuring quality, affordable, and accessible cancer care. This will include 2 days full of learning and networking with community oncology practices and allied...

The...

02/19/2019

Journal of Clinical Pathways

Editorial

Charting a Path Forward for the Oncology Care Model

11/18/2018

Nicolas Ferreyros ;

The Oncology Care Model (OCM) is a federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while...

The...

11/18/2018

Journal of Clinical Pathways